IR is present in approximately 25% of NGT individuals.[64] Given the multiple well established relationships between obesity/IR and severe metabolic disorders (including the metabolic syndrome, hypertension and cardiovascular disease) it remains the case that disordered regulation of ADH1B expression may be involved in manifold complex metabolic diseases with a high societal and economic burden. Here, ADH1B is linked to hypertensive disorder.